GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Exam Corner/Microvillus Inclusion Disease
50

Microvillus Inclusion Disease

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2025

Microvillus Inclusion Disease (MVID) is a rare, congenital intestinal disorder that primarily affects infants and newborns. It is caused by genetic mutations that disrupt the normal function of the epithelial cells lining the small intestine, leading to life-threatening diarrhea and severe malabsorption.


Key Features of MVID

1. What Happens in MVID?

  • Microvilli, which are tiny finger-like projections on the surface of intestinal cells (enterocytes), are either absent or abnormally trapped inside the cells in vesicles called "microvillus inclusions."
  • Microvilli are essential for nutrient absorption, and their dysfunction leads to severe diarrhea and inability to absorb nutrients.

2. Genetic Cause

  • MVID is caused by mutations in genes involved in intracellular trafficking:
  • MYO5B: Most common mutation.
  • STX3 and STXBP2: Less common mutations.
  • It is inherited in an autosomal recessive manner, meaning both parents must pass on a defective gene for the child to develop the disease.

3. Clinical Symptoms

  • Symptoms usually appear within the first days or weeks of life.
  • Severe diarrhea: Watery and persistent.
  • Dehydration: Due to fluid loss.
  • Failure to thrive: Poor growth and malnutrition.
  • Electrolyte imbalance: Low levels of essential minerals due to diarrhea.
  • Complications:
  • Dependence on parenteral nutrition (IV feeding).
  • Risk of infections, liver damage, and sepsis from long-term IV feeding.

Diagnosis

  • Histopathology and Electron Microscopy:
  • Flattened villi in the intestine (villus atrophy).
  • Microvillus inclusions visible inside enterocytes.
  • Genetic Testing: Identifies mutations in MYO5B, STX3, or STXBP2 genes.
  • Immunohistochemistry: May show abnormal protein expression in epithelial cells.

Treatment

  • No Cure: MVID cannot be cured, but symptoms can be managed.
  • Supportive Care:
  • Total Parenteral Nutrition (TPN): Provides nutrients intravenously to ensure growth and survival.
  • Infection control: Prevent complications like sepsis.
  • Intestinal Transplantation:
  • In severe cases, intestinal or combined liver–intestine transplantation may be considered for long-term survival.

Prognosis

  • Without transplantation, prognosis is poor due to complications from TPN (e.g., infections, liver damage).
  • Advances in transplant surgery and supportive care have improved survival rates.

In Simple Terms

Microvillus Inclusion Disease is a genetic disorder where babies are unable to absorb nutrients because their intestinal cells lack functioning microvilli. This leads to severe diarrhea, malnutrition, and dependence on IV feeding to survive. Treatment focuses on managing symptoms, and intestinal transplantation may offer a chance for better long-term outcomes.

Would you like additional information on genetic inheritance patterns, recent research, or support groups for families dealing with MVID?

Related Q&A

51

Leptin Vs Ghrelin

Ghrelin and leptin are two pivotal hormones that regulate appetite, energy balance, and metabolism. They work in opposing ways, yet their interplay is crucial for maintaining the body’s...

52

What is Metagenome

A metagenome is the complete collection of genetic material (DNA and sometimes RNA) extracted directly from an environmental sample, rather than from a single, isolated organism. In essence,...

53

SG Dilators

Savary-Gilliard (SG) Dilators are highly effective, wire-guided mechanical bougies widely used in gastroenterology for esophageal dilation. They are designed to treat various esophageal strictures and conditions by providing...

54

CRE Balloon Vs Rigiflex Balloon

CRE Balloon vs Rigiflex Balloon: A Comprehensive Comparison Both CRE Balloon and Rigiflex Balloon are widely used medical devices for dilation procedures in the gastrointestinal tract, but their...

55

Differentiating between intraperitoneal and retroperitoneal lumps

Differentiating between intraperitoneal and retroperitoneal lumps is crucial for accurate diagnosis, management, and treatment planning. Below is a detailed explanation of the differences based on clinical examination, anatomical...

56

Immune Modulators in HBV therapy

Immune modulators in HBV therapy aim to restore or augment the host immune response against the hepatitis B virus (HBV). Chronic HBV infection is often characterized by immune...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer